SCHEMBL3787182

SCHEMBL3787182

CC(C)COC(=O)N1CCC(CSc2ncc(C(C)(C)c3ccc(F)c(F)c3)n2-c2ccc(F)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 18/20 0.42
NR1H4 Q96RI1 1/20 0.38
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL602033 0.89 GPBAR1 (0.43) GPBAR1NR1H4
SCHEMBL3794976 0.87 GPBAR1 (0.48) GPBAR1NR1H4RORC
SCHEMBL605584 0.86 GPBAR1 (0.41) GPBAR1NR1H4
SCHEMBL602078 0.82 GPBAR1 (0.44) GPBAR1NR1H4
SCHEMBL13259313 0.81 GPBAR1 (0.36) GPBAR1NR1H4
SCHEMBL601075 0.80 GPBAR1 (0.42) GPBAR1NR1H4
SCHEMBL10227887 0.80 GPBAR1 (0.46) GPBAR1NR1H4
SCHEMBL601931 0.78 GPBAR1 (0.53) GPBAR1NR1H4
SCHEMBL601054 0.76 GPBAR1 (0.51) GPBAR1NR1H4
SCHEMBL3792941 0.74 GPBAR1 (0.42) GPBAR1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396304-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY Exelixis, Inc. (US) 2011-12-21 EP claimed
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO claimed